From July, 2012, Eugene Robinson writes: This is an amazing accomplishment, especially because it wasn’t supposed to be possible.
Before PEPFAR, the conventional wisdom was that the drug-treatment regimens that were saving lives in developed countries would not work in Africa. Poor, uneducated people in communities lacking even the most basic infrastructure could not be expected to take the right pill at the right time every day. When the drugs are taken haphazardly, the virus mutates and becomes resistant. Therefore, this reasoning went, trying to administer antiretroviral treatment in poor African countries might actually be worse than doing nothing at all.
The Bush administration rejected these arguments, which turned out to be categorically wrong.
Africans are every bit as diligent about taking their HIV medications as are Americans or other Westerners. While there has been a “modest, contained and not alarming” rise in resistance to one class of drugs, according to a World Health Organization researcher who presented a study at this week’s AIDS conference, scientists no longer envision a nightmare scenario in which drug-resistant strains of the virus run rampant.